Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yuliet Bermúdez-Hernández"'
Autor:
Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 184-188
The treatment of chronic hepatitis C with interferon alpha (IFN-a) is widely used. However, the relapse rate is high, and sustained response is only in 10-20%. A combined treatment based on the synergic antiviral effects described for IFN-a and ribav
Externí odkaz:
https://doaj.org/article/f3c2c2e4ff484170b52c4545adaabdd3
Autor:
Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 3, Pp 184-188
The treatment of chronic hepatitis C with interferon alpha (IFN-a) is widely used. However, the relapse rate is high, and sustained response is only in 10-20%. A combined treatment based on the synergic antiviral effects described for IFN-a and ribav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ce1350501a56ee90114742524b979d8a
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522012000300005&lng=en&tlng=en
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522012000300005&lng=en&tlng=en